Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes

Vaccination strategy that induce efficient antibody responses polytopically in most lymph nodes (LNs) against infections has not been established yet. Because donor-specific blood transfusion induces anti-donor class I MHC antibody production in splenectomized rats, we examined the mechanism and sig...

Full description

Bibliographic Details
Main Authors: Yusuke Kitazawa, Hisashi Ueta, Yasushi Sawanobori, Tomoya Katakai, Hiroyuki Yoneyama, Satoshi Ueha, Kouji Matsushima, Nobuko Tokuda, Kenjiro Matsuno
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01195/full
_version_ 1818294339325919232
author Yusuke Kitazawa
Hisashi Ueta
Yasushi Sawanobori
Tomoya Katakai
Hiroyuki Yoneyama
Satoshi Ueha
Kouji Matsushima
Nobuko Tokuda
Kenjiro Matsuno
author_facet Yusuke Kitazawa
Hisashi Ueta
Yasushi Sawanobori
Tomoya Katakai
Hiroyuki Yoneyama
Satoshi Ueha
Kouji Matsushima
Nobuko Tokuda
Kenjiro Matsuno
author_sort Yusuke Kitazawa
collection DOAJ
description Vaccination strategy that induce efficient antibody responses polytopically in most lymph nodes (LNs) against infections has not been established yet. Because donor-specific blood transfusion induces anti-donor class I MHC antibody production in splenectomized rats, we examined the mechanism and significance of this response. Among the donor blood components, T cells were the most efficient immunogens, inducing recipient T cell and B cell proliferative responses not only in the spleen, but also in the peripheral and gut LNs. Donor T cells soon migrated to the splenic T cell area and the LNs, with a temporary significant increase in recipient NK cells. XCR1+ resident dendritic cells (DCs), but not XCR1− DCs, selectively phagocytosed donor class I MHC+ fragments after 1 day. After 1.5 days, both DC subsets formed clusters with recipient CD4+ T cells, which proliferated within these clusters. Inhibition of donor T cell migration or depletion of NK cells by pretreatment with pertussis toxin or anti-asialoGM1 antibody, respectively, significantly suppressed DC phagocytosis and subsequent immune responses. Three allogeneic strains with different NK activities had the same response but with different intensity. Donor T cell proliferation was not required, indicating that the graft vs. host reaction is dispensable. Intravenous transfer of antigen-labeled and mitotic inhibitor-treated allogeneic, but not syngeneic, T cells induced a polytopical antibody response to labeled antigens in the LNs of splenectomized rats. These results demonstrate a novel mechanism of alloresponses polytopically in the secondary lymphoid organs (SLOs) induced by allogeneic T cells. Donor T cells behave as self-migratory antigen ferries to be delivered to resident XCR1+ DCs with negligible commitment of migratory DCs. Allogeneic T cells may be clinically applicable as vaccine vectors for polytopical prophylactic antibody production even in asplenic or hyposplenic individuals.
first_indexed 2024-12-13T03:30:11Z
format Article
id doaj.art-c1c18ae551c54cc9a72c1d641352e0d2
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-13T03:30:11Z
publishDate 2019-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-c1c18ae551c54cc9a72c1d641352e0d22022-12-22T00:01:11ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-05-011010.3389/fimmu.2019.01195429784Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph NodesYusuke Kitazawa0Hisashi Ueta1Yasushi Sawanobori2Tomoya Katakai3Hiroyuki Yoneyama4Satoshi Ueha5Kouji Matsushima6Nobuko Tokuda7Kenjiro Matsuno8Department of Anatomy (Macro), School of Medicine, Dokkyo Medical University, Tochigi, JapanDepartment of Anatomy (Macro), School of Medicine, Dokkyo Medical University, Tochigi, JapanDepartment of Anatomy (Macro), School of Medicine, Dokkyo Medical University, Tochigi, JapanDepartment of Immunology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JapanTME Therapeutics Inc., Tokyo, JapanDivision of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, JapanDivision of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, JapanDepartment of Anatomy (Macro), School of Medicine, Dokkyo Medical University, Tochigi, JapanDepartment of Anatomy (Macro), School of Medicine, Dokkyo Medical University, Tochigi, JapanVaccination strategy that induce efficient antibody responses polytopically in most lymph nodes (LNs) against infections has not been established yet. Because donor-specific blood transfusion induces anti-donor class I MHC antibody production in splenectomized rats, we examined the mechanism and significance of this response. Among the donor blood components, T cells were the most efficient immunogens, inducing recipient T cell and B cell proliferative responses not only in the spleen, but also in the peripheral and gut LNs. Donor T cells soon migrated to the splenic T cell area and the LNs, with a temporary significant increase in recipient NK cells. XCR1+ resident dendritic cells (DCs), but not XCR1− DCs, selectively phagocytosed donor class I MHC+ fragments after 1 day. After 1.5 days, both DC subsets formed clusters with recipient CD4+ T cells, which proliferated within these clusters. Inhibition of donor T cell migration or depletion of NK cells by pretreatment with pertussis toxin or anti-asialoGM1 antibody, respectively, significantly suppressed DC phagocytosis and subsequent immune responses. Three allogeneic strains with different NK activities had the same response but with different intensity. Donor T cell proliferation was not required, indicating that the graft vs. host reaction is dispensable. Intravenous transfer of antigen-labeled and mitotic inhibitor-treated allogeneic, but not syngeneic, T cells induced a polytopical antibody response to labeled antigens in the LNs of splenectomized rats. These results demonstrate a novel mechanism of alloresponses polytopically in the secondary lymphoid organs (SLOs) induced by allogeneic T cells. Donor T cells behave as self-migratory antigen ferries to be delivered to resident XCR1+ DCs with negligible commitment of migratory DCs. Allogeneic T cells may be clinically applicable as vaccine vectors for polytopical prophylactic antibody production even in asplenic or hyposplenic individuals.https://www.frontiersin.org/article/10.3389/fimmu.2019.01195/fulldendritic cell targetingallogeneic T cellvaccinationaspleniapolytopical antibody productionlymph nodes
spellingShingle Yusuke Kitazawa
Hisashi Ueta
Yasushi Sawanobori
Tomoya Katakai
Hiroyuki Yoneyama
Satoshi Ueha
Kouji Matsushima
Nobuko Tokuda
Kenjiro Matsuno
Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes
Frontiers in Immunology
dendritic cell targeting
allogeneic T cell
vaccination
asplenia
polytopical antibody production
lymph nodes
title Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes
title_full Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes
title_fullStr Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes
title_full_unstemmed Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes
title_short Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes
title_sort novel targeting to xcr1 dendritic cells using allogeneic t cells for polytopical antibody responses in the lymph nodes
topic dendritic cell targeting
allogeneic T cell
vaccination
asplenia
polytopical antibody production
lymph nodes
url https://www.frontiersin.org/article/10.3389/fimmu.2019.01195/full
work_keys_str_mv AT yusukekitazawa noveltargetingtoxcr1dendriticcellsusingallogeneictcellsforpolytopicalantibodyresponsesinthelymphnodes
AT hisashiueta noveltargetingtoxcr1dendriticcellsusingallogeneictcellsforpolytopicalantibodyresponsesinthelymphnodes
AT yasushisawanobori noveltargetingtoxcr1dendriticcellsusingallogeneictcellsforpolytopicalantibodyresponsesinthelymphnodes
AT tomoyakatakai noveltargetingtoxcr1dendriticcellsusingallogeneictcellsforpolytopicalantibodyresponsesinthelymphnodes
AT hiroyukiyoneyama noveltargetingtoxcr1dendriticcellsusingallogeneictcellsforpolytopicalantibodyresponsesinthelymphnodes
AT satoshiueha noveltargetingtoxcr1dendriticcellsusingallogeneictcellsforpolytopicalantibodyresponsesinthelymphnodes
AT koujimatsushima noveltargetingtoxcr1dendriticcellsusingallogeneictcellsforpolytopicalantibodyresponsesinthelymphnodes
AT nobukotokuda noveltargetingtoxcr1dendriticcellsusingallogeneictcellsforpolytopicalantibodyresponsesinthelymphnodes
AT kenjiromatsuno noveltargetingtoxcr1dendriticcellsusingallogeneictcellsforpolytopicalantibodyresponsesinthelymphnodes